Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
11
×
life sciences
national blog main
boston blog main
boston top stories
san francisco blog main
fda
new york blog main
new york top stories
san francisco top stories
national top stories
deals
investing
national
raleigh-durham blog main
raleigh-durham top stories
startups
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medical device
san diego blog main
san diego top stories
seattle blog main
seattle top stories
springworks therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
biotech ipos
boston
cancer
cancer drugs
What
biotech
11
×
ipo
drug
companies
days
new
research
roundup
bio
medicines
raised
week
annual
attention
cancer
company
genetic
hasn’t
ipos
lead
leading
life
markets
million
news
public
raises
satsuma
science
slowed
springworks
street
therapeutics
wall
way
welcomed
abbvie
according
activity
ahead
Language
unset
Current search:
biotech
×
" clinical trials "
×
@xconomy.com
4 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More